Cancer Family
Respiratory System Neoplasm
CI-CAN-00000049Explore in graph →
Non-malignant2,725 active trials51 approved drugs619 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000049Explore in graph →
Clinical trials
11,608 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00061464 | Pemetrexed Plus Gemcitabine for Patients With Locally Advanced or Metastatic NSCLC Who Have Not Had Previous Chemotherapy. | completed | Phase 2 | 48 | Eli Lilly and CompanyINDUSTRY | 1 | Jan 26, 2007 | clinicaltrials |
| NCT00071136 | Pemetrexed and Gemcitabine in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 1 / Phase 2 | 48 | Eli Lilly and CompanyINDUSTRY | 1 | Jan 26, 2007 | clinicaltrials |
| NCT00190840 | A Single Arm Phase 2 Study of Pemetrexed as 2nd-Line Treatment of Advanced Non-Small Cell Lung Cancer | completed | Phase 2 | 186 | Eli Lilly and CompanyINDUSTRY | 8 | Jan 26, 2007 | clinicaltrials |
| NCT00191230 | Gemcitabine/Platinum Containing Regimens as Preoperative Chemotherapy for Patients With Non Small Cell Lung Cancer | completed | Phase 2 | 70 | Eli Lilly and CompanyINDUSTRY | 1 | Jan 26, 2007 | clinicaltrials |
| NCT00191256 | Efficacy Trial of Gemcitabine Containing Regimens As Preoperative Chemotherapy in Non Small Cell Lung Cancer | completed | Phase 2 | 77 | Eli Lilly and CompanyINDUSTRY | 1 | Jan 26, 2007 | clinicaltrials |
| NCT00191490 | A Randomized Study Evaluating the Feasibility and Activity of Three Different Combination With Gemcitabine as First Line Therapy for Non Small Cell Lung Cancer | completed | Phase 2 | 162 | Eli Lilly and CompanyINDUSTRY | 1 | Jan 26, 2007 | clinicaltrials |
| NCT00191620 | Study Comparing Short Infusion Vs. Fixed Dose of Cisplatin + Gemcitabine in Non Small Cell Lung Cancer. | completed | Phase 2 | 64 | Eli Lilly and CompanyINDUSTRY | 4 | Jan 26, 2007 | clinicaltrials |
| NCT00260026 | Safety and Pharmacokinetics of Jin Fu Kang in Comb w/Docetaxel for Patients w/Non-Small Cell Lung Cancer | completed | Phase 2 | 20 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jan 26, 2007 | clinicaltrials |
| NCT00232128 | Protocol for Radiofrequency Ablation of Pulmonary Neoplasms | terminated | N/A | — | Oncology Specialties, AlabamaOTHER | 1 | Jan 12, 2007 | clinicaltrials |
| NCT00420862 | The DANTE Trial. A Randomized Study on Lung Cancer Screening With Low-Dose Spiral Computed Tomography | terminated | Phase 3 | 2,400 | Istituto Clinico HumanitasOTHER | 1 | Jan 11, 2007 | clinicaltrials |
| NCT00179686 | A Study to Evaluate the Single-Agent Lenalidomide in Subjects With Recurrent Non-Small-Cell Lung Cancer | completed | Phase 2 | 40 | Celgene CorporationINDUSTRY | 1 | Dec 20, 2006 | clinicaltrials |
| NCT00062907 | Safety and Immunogenicity of Recombinant DNA and Adenovirus Expressing L523S Protein in Early Stage Non-Small Cell Lung Cancer | unknown | Phase 1 | 9 | Corixa CorporationINDUSTRY | 1 | Dec 6, 2006 | clinicaltrials |
| NCT00407264 | Randomized Trial of Fluticasone in Bronchial Premalignancy | completed | Phase 2 | 90 | Amsterdam UMC, location VUmcOTHER | 1 | Dec 4, 2006 | clinicaltrials |
| NCT00074854 | A Clinical Efficacy Study Of An Oral Tyrosine Kinase Inhibitor Of VEGFR-2 Given In Combination With Chemotherapy | completed | Phase 1 / Phase 2 | 87 | PfizerINDUSTRY | 1 | Nov 9, 2006 | clinicaltrials |
| NCT00050830 | A Phase 2, Randomized, Open-Label Study Of Single Agent CI-1033 In Patients With Advanced Non-Small Cell Lung Cancer | completed | Phase 2 | 163 | PfizerINDUSTRY | 8 | Nov 8, 2006 | clinicaltrials |
| NCT00174356 | PH 1 Evaluation Of Oral CI-1033 In Combination With Paclitaxel/ Carboplatin As 1st Line Chemotherapy In NSCLC Patients | completed | Phase 1 | 39 | PfizerINDUSTRY | 2 | Nov 8, 2006 | clinicaltrials |
| NCT00397124 | The Role of the Vagus Nerve in Tumor-to-Brain Communication in Lung Cancer Patients | unknown | N/A | 40 | Rambam Health Care CampusOTHER | 1 | Nov 8, 2006 | clinicaltrials |
| NCT00168883 | Study for Patients With Non Small Cell Lung Cancer (NSCLC) | unknown | Phase 2 | 80 | Charite University, Berlin, GermanyOTHER | 1 | Nov 1, 2006 | clinicaltrials |
| NCT00241267 | Bronchial Ultrasonography Via a Fibrescope: Pilot Study in Tumoral Disease | terminated | — | 20 | University Hospital, ToursOTHER | 1 | Oct 6, 2006 | clinicaltrials |
| NCT00067691 | Acupuncture for Shortness of Breath in Cancer Patients | completed | N/A | 40 | National Center for Complementary and Integrative Health (NCCIH)NIH | 1 | Aug 18, 2006 | clinicaltrials |
| NCT00364663 | The Utility and Cost-Effectiveness Analysis of 18F-FDG PETin Staging Potential Operable Non-Small Cell Lung Cancer | unknown | — | 100 | National Taiwan University HospitalOTHER | 1 | Aug 16, 2006 | clinicaltrials |
| NCT00191841 | Gemcitabine in Combination With Cisplatin as Neoadjuvant NSCLC Chemotherapy | completed | Phase 2 | 50 | Eli Lilly and CompanyINDUSTRY | 1 | Jul 24, 2006 | clinicaltrials |
| NCT00051506 | ALIMTA(Pemetrexed)/Cisplatin and ALIMTA(Pemetrexed)/Carboplatin in Extensive Stage Small Cell Lung Cancer. | completed | Phase 2 | — | Eli Lilly and CompanyINDUSTRY | 1 | Jul 20, 2006 | clinicaltrials |
| NCT00034268 | A Phase 3 Trial of LY900003 Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in Patients With Advanced, Previously Untreated Non-Small Cell Lung Cancer | completed | Phase 3 | — | Eli Lilly and CompanyINDUSTRY | 21 | Jul 19, 2006 | clinicaltrials |
| NCT00034606 | Comparing 3 Schedules of Alimta Plus Gemzar | completed | Phase 2 | — | Eli Lilly and CompanyINDUSTRY | 1 | Jul 19, 2006 | clinicaltrials |
| NCT00042679 | A Phase 2 Trial of Antisense Nucleotide to PKC-Alpha (LY900003, ISIS 3521) Plus Gemcitabine and Carboplatin in Patients With Advanced, Previously Untreated Non-Small Cell Lung Cancer. | completed | Phase 2 | — | Eli Lilly and CompanyINDUSTRY | 1 | Jul 19, 2006 | clinicaltrials |
| NCT00051493 | ALIMTA Plus Carboplatin as Front-Line Chemotherapy for Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer: A Phase 2 Clinical Trial. | completed | Phase 2 | 50 | Eli Lilly and CompanyINDUSTRY | 1 | Jul 19, 2006 | clinicaltrials |
| NCT00339586 | First-Line EGFR-1 Tyrosine Kinase Inhibition in Patients With NSCLC With Mutant EGFR Gene | unknown | Phase 2 | 40 | Universitair Ziekenhuis BrusselOTHER | 1 | Jun 21, 2006 | clinicaltrials |
| NCT00285675 | Study of DN-101 (Calcitriol) and Docetaxel in Subjects Previously Enrolled in Studies DN101-002 or DN101-004 | unknown | Phase 2 | 25 | NovaceaINDUSTRY | 2 | May 31, 2006 | clinicaltrials |
| NCT00168922 | Study to Determine the Efficacy of Bendamustin in Patients With Recurrent Small Cell Lung Cancer (SCLC) | unknown | Phase 2 | 50 | Charite University, Berlin, GermanyOTHER | 1 | Apr 27, 2006 | clinicaltrials |
| NCT00082472 | Inhaled Doxorubicin Plus IV Docetaxel and Cisplatin in Patients With Non-Small-Cell Lung Carcinoma (NSCLC) | unknown | Phase 1 / Phase 2 | 30 | ZivenaINDUSTRY | 1 | Apr 18, 2006 | clinicaltrials |
| NCT00311207 | Development of Tuberculosis Diagnostic Kit | unknown | — | 200 | Taichung Veterans General HospitalOTHER | 1 | Apr 5, 2006 | clinicaltrials |
| NCT00257179 | The Serum Tissue Factor Level in Lung Cancer Patients as a Prognostic Factor | unknown | — | 200 | National Taiwan University HospitalOTHER | 1 | Mar 14, 2006 | clinicaltrials |
| NCT00268684 | Comparison Study of WBRT and SRS Alone Versus With Temozolomide or Erlotinib in Patients With Brain Metastases of NSCLC | unknown | Phase 3 | 381 | Tel-Aviv Sourasky Medical CenterOTHER_GOV | 1 | Feb 28, 2006 | clinicaltrials |
| NCT00168896 | A Study for Small Cell Lung Cancer (SCLC) in Extensive Disease Stage | unknown | Phase 2 / Phase 3 | 286 | Charite University, Berlin, GermanyOTHER | 1 | Feb 14, 2006 | clinicaltrials |
| NCT00139971 | Phase III Study of Gemcitabine Compared With UFT in Patients With Completely Resected Pathological Stage IB-IIIa Non Small Cell Lung Cancer | unknown | Phase 3 | 600 | West Japan Thoracic Oncology GroupOTHER | 1 | Jan 6, 2006 | clinicaltrials |
| NCT00144053 | A Phase Ⅲ Randomized Study of Mitomycin/Vindesine/Cisplatin Versus Irinotecan/Carboplatin Versus Paclitaxel/Carboplatin With Concurrent Thoracic Radiotherapy for Unresectable Stage Ⅲ Non-Small-Cell Lung Cancer | completed | Phase 3 | 450 | West Japan Thoracic Oncology GroupOTHER | 0 | Jan 6, 2006 | clinicaltrials |
| NCT00148291 | Phase III Study of Docetaxel Vs Vinorelbine in Elderly Patients With Advanced Non-Small Cell Lung Cancer | completed | Phase 3 | 180 | West Japan Thoracic Oncology GroupOTHER | 0 | Jan 6, 2006 | clinicaltrials |
| NCT00265694 | Random Trial for Elderly Patients With NSCLC | unknown | Phase 3 | — | Inje UniversityOTHER | 1 | Dec 15, 2005 | clinicaltrials |
| NCT00150657 | Study of Carboplatin/Gemcitabine Plus Bevacizumab in Advanced Lung Cancer | unknown | Phase 2 | 45 | St. John Providence Health SystemOTHER | 1 | Nov 29, 2005 | clinicaltrials |
| NCT00173680 | Methylation Status of CD44 Promoter Region in Primary Lung Cancer | unknown | — | 40 | National Taiwan University HospitalOTHER | 1 | Nov 24, 2005 | clinicaltrials |
| NCT00155116 | SERPIN D1 and Its Role in Lung Cancer Invasion and Metastasis | unknown | — | 100 | National Taiwan University HospitalOTHER | 1 | Nov 23, 2005 | clinicaltrials |
| NCT00254319 | Previously Untreated Advanced Non-Small Cell Lung Cancer (NSCLC) | unknown | Phase 2 | — | The Cooper Health SystemOTHER | 1 | Nov 16, 2005 | clinicaltrials |
| NCT00238849 | Phase II Study of Oxaliplatin and Navelbine for Second-Line Treatment of Advanced NSCLC. | unknown | Phase 2 | 40 | Integrated Community Oncology NetworkOTHER | 1 | Oct 14, 2005 | clinicaltrials |
| NCT00130143 | Toxicities Associated With Subcutaneous Administration of Ethyol (Amifostine) for the Prevention of Radiation-Induced Toxicities | completed | N/A | 20 | The Dale & Frances Hughes Cancer CenterOTHER | 1 | Sep 27, 2005 | clinicaltrials |
| NCT00211952 | Adjuvant Celecoxib in Completely Resected pN1-2 NSCLC Patients | suspended | Phase 3 | 542 | Medical University of GdanskOTHER | 1 | Sep 21, 2005 | clinicaltrials |
| NCT00187980 | Sleep Disturbance in Lung Cancer Patients. | unknown | — | 50 | University Hospital, AngersOTHER_GOV | 1 | Sep 16, 2005 | clinicaltrials |
| NCT00172575 | Differentiation of Malig. & Ben. Solitary Pulm. Nodules & Prediction of Clin. Outcome Using Perfus. Analysis of DCEMRI | unknown | — | 60 | National Taiwan University HospitalOTHER | 1 | Sep 15, 2005 | clinicaltrials |
| NCT00175747 | A Phase IIb Trial of Pulmicort Turbuhaler (Budesonide) | completed | Phase 2 / Phase 3 | 120 | University of British ColumbiaOTHER | 1 | Sep 15, 2005 | clinicaltrials |
Data updated 22 days agoSource updated Jan 26, 2007source: clinicaltrials